Novartis Changes Direct-to-Consumer Ads for Kisqali
Novartis was forced to change some of the claims it was making in its direct-to consumer advertising about the breast cancer drug Kisqali (ribociclib) after a challenge from Lilly.
Medscape Medical News
source https://www.medscape.com/viewarticle/987533?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/987533?src=rss
Comments
Post a Comment